Get Adobe Flash player

EFFECT OF BUSPIRONE HYDROCHLORIDE ON DISPERSION OF VENTRICULAR REPOLARIZATION IN PATIENTS WITH ANXIETY-DEPRESSIVE DISORDERS AND CHRONIC HEART FAILURE OF ISCHEMIC ETIOLOGY

Authors: Khrystychenko M.A. 

Pages: 209-215

Abstract

 

The purpose of the study was to investigate the effect of buspirone hydrochloride on QT interval dispersion (ΔQT) in patients with chronic heart failure (CHF) of ischemic etiology with anxiety and depressive disorders (ADD).

 

142 patients (85 males, 57 females; mean age 66.4 ± 10.5) NYHA II-IV were randomized into the study. All patients were prescribed buspirone hydrochloride 10 mg t.i.d. due to anxiety and depressive disorders. All patients had II-III functional classes of angina; 86 of them (60.6 %) had history of myocardial infarction. Randomized patients received standard CHF and coronary heart disease therapy. Informed consents were signed before the study initiation. Exclusion criteria were history of mental disorders, significant impairment of cognitive functions, alcohol/drug abuse, other psychoactive drug intake, and severe concomitant pathology. 

According to the results of Hospital Anxiety and Depression Scale (HADS), Beck Depression Questionnaire and Spielberger Anxiety Scale all patients were divided into two groups: the 1st with ADD, the 2nd – without them. 

Initially and in 3 months of buspirone hydrochloride intake rest ECG was recorded in 12 standard leads, 50 mm/s and QT (ΔQT) and QTc (ΔQTс) dispersions were calculated by the standard technique (DQT = QTmax – QТmin, ΔQTc = QTc max – QTc min). 

Initially mean ΔQT and ΔQTc for patients of the group 1 were 58.5 ± 11.0 ms and 57.8 ± 10.4 ms, respectively, 32.0 ± 9.7 and 31.2 ± 8.6 ms for the group 2. At re-examination ΔQT had no statistically significant differences in comparison with initial data and between groups (462.3±74.1 msand 454.0 ±66.2 msforthe groups 1 and 2, respectively) (p > 0.05).

Buspirone hydrochloride treatment did not lead to increase of dispersion of ventricular repolarization in the patients with ischemic CHF.

Key words: anxiety-depressive disorders, chronic heart failure, dispersion of ventricular repolarization, buspirone hydrochloride.

        This email address is being protected from spambots. You need JavaScript enabled to view it.   

The full text

To view the full text

References

  1. Gretchen A. Anxiety, depression, and quality of life in primary care patients, prim care companion. Primary Сare ССlinical Psychiatry. 2007;9(6):437–443.
  2. Vatutin NT, Кalinkina NV, Каrtamysheva YeV, Khrystychenko МА, Yeshenko YeV. [Depression and chronic heart failure]. Ukrainian Cardiology Journal. 2013;3:117–124.
  3. Havranek E, Ware M, Lowes B. Prevalence of depression in congestive heart failure. American Journal of Cardiology. 2009;84:348–350.
  4. Vatutin NT, Khrystychenko МА, Каrtamysheva YeV, Кеting EV. [Depression and cardiovascular diseases]. Circulation and Hemostasis. 2013;2:72–79.
  5. Carels RA. The association between disease severity, functional status, depression and daily quality of life in congestive heart failure patients. Quality of Life Research: an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 2004,13(1):63–72.
  6. Szygula-Jurkiewicz B, Duszanska A., Polonski L. Is depression a problem in patients with chronic heart failure? Pol Arch Med Wewn. 2008;118(1–2):52–56.
  7. Kelmanson IA. High anxiety in clinically healthy patients and increased QT dispersion: A meta-analysis. European JPreventive Cardiology. 2013;14:343–349.
  8. Vatutin NT, Кеting EV, Khrystychenko МА, Adarichev VV. [Dispersion of ventricular repolarization in depressive patients with chronic heart failure of ischemic etiology]. XIII kongress serdechnaia nedostatochnost 2013 [Proceedings of XIII Congress: Heart failure 2013]. Moscow, 2013.
  9. Khrystychenko МА, Каrtamysheva YeV, Degtyarova АE. [Effect of buspirone hydrochloride on the correction of anxiety disorders in patients with chronic heart failure of ischemic etiology]. 75 mizhnarodnyi medychnyi kongres molodykh vchenykh [Proceedings of scientific conference: 75 international medical congress of young scientists]. Donetsk National Medical University Publ., 2013, pp. 124–125. (in Russian).
  10. Vatutin NT, Khrystychenko МА, Кеting ЕV, Zagoruyko АN. [Dispersion of ventricular repolarization in patients with chronic heart failure of ischemic etiology: relationship with depressive and anxiety disorders]. Mizhnarodna naukovo-praktychna konferenciia z mizhnarodnoiu uchastiu [Proceeding of scientific conference: science-practical conference with international participation]. Kharkiv, 2013, pp. 49. (in Russian).
  11. Holzapfel N, Lowe B, Wild B, Schellberg D, Zugck C, Remppis A, Katus HA, Haass M, Rauch B, Junger J, Herzog W, Muller-Tasch T. Self-care and depression in patients with chronic heart failure. Heart Lung. 2009;38(5):392–7. doi: 10.1016/j.hrtlng.2008.11.001.
  12. Albert NM, Fonarow GC, Abraham WT, Gheorghiade M, Greenberg BH, Nunez E, O'Connor CM, Stough WG, Yancy CW, Young JB. Depression and clinical outcomes in heart failure: an OPTIMIZE-HF analysis. The American JMedicine. 2009;122(4):366–73. doi: 10.1016/j.amjmed.2008.09.046.
  13. Gryn VК, Кеting ЕV, Каlinkinа NV, Vatutin NТ. QT Dispersiia [QT Dispersion]. Donetsk: UkrNТEК Publ., 2003. 193 p.
  14. Faller H, Angermann CE. [Depression in chronic heart failure: complication, risk factor or autonomous disease?] Internist (Berl). 2008;49(4):394, 396–8, 400, 402–4. doi: 10.1007/s00108-008-2048-5.
  15. Thomas SA, Chapa DW, Friedmann E, Durden C, Ross A, Lee MC, Lee HJ. Depression in patients with heart failure. Prevalence, pathophysiological mechanisms, and treatment. Critical Care Nurse. 2008;28(2):40–55.
  16. Atmaca M, Yavuzkir M, İzci F, Gurok MG, Adiyaman S. QT wave dispersion in patients with panic disorder. Neuroscience Bulletin. 2012;28(3):247–52.